Torrent Settles With BMS For Revlimid, Launch Timeline Undisclosed
US Injectables Entry Under ‘Constant Evaluation’
Torrent has reached a settlement with BMS’ Celgene over oncology blockbuster Revlimid, officials said during a Q2 call, but declined to disclose launch timelines for the generic. Meanwhile, the Indian company continues to evaluate an option to enter the injectables segment in the US as revenues slide.
